• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
 

2006 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2006

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
May 16, 2006 CHS, Incorporated [ARCHIVED] Seattle District Office Current Good Manufacturing Practice Regulations for Medicated Feeds/Adulterated N/A *
May 15, 2006 Eagle Livestock Inc [ARCHIVED] Los Angeles District Office Illegal Drug Residue N/A *
May 15, 2006 Therics, LLC [ARCHIVED] New Jersey District Office Quality System Regulations/Medical Device Reporting/Adulterated/Misbranded N/A *
May 11, 2006 Talcon Acrylics, Incorporated [ARCHIVED] Seattle District Office Lacks Premarket Approval Application Misbranded N/A *
May 11, 2006 Dae Han Tofu Company [ARCHIVED] Seattle District Office Labeling/False & Misleading Claims/Misbranded N/A *
May 11, 2006 North American Science Associates, Inc. [ARCHIVED] Center for Drug Evaluation and Research GLP for non-clincal laboratory studies N/A *
May 09, 2006 Wagler Farms [ARCHIVED] Detroit District Office Illegal Drug Residue in Edible Animal Tissue/Adulterated N/A *
May 08, 2006 Wyeth Pharmaceuticals Company [ARCHIVED] San Juan District Office Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated N/A *
May 08, 2006 Van Heel, David B. [ARCHIVED] Minneapolis District Office Illegal Drug Residue/Extralabel Drug Use/Adulterated N/A *
May 05, 2006 Creative Medical Corporation [ARCHIVED] San Juan District Office OTC Drug Products/Dietary Supplements/Misbranded N/A *
May 04, 2006 Pomeroy, Ed M. [ARCHIVED] Seattle District Office Illegal Drug Residue in Animal Tissue/Extralabel Drug Use/Adulterated N/A *
May 03, 2006 Tri-State Hospital Supply Corporation [ARCHIVED] Atlanta District Office Current Good Manufacturing Practice for Medical Devices/Adulterated N/A *
May 03, 2006 Aquarium Products [ARCHIVED] Baltimore District Office CGMP Regulations for Finished Pharmaceuticals/Adulterated N/A *
May 02, 2006 Dee Creek Farm [ARCHIVED] Seattle District Office Control of Communicable Diseases/Adulterated N/A *
May 02, 2006 Del Mar Seafood Inc [ARCHIVED] Florida District Office Seafood HACCP/Adulterated N/A *
May 02, 2006 Tropical Marine Products Inc. [ARCHIVED] Florida District Office Seafood HACCP/Adulterated N/A *
April 28, 2006 Pliva Croatia Ltd [ARCHIVED] Center for Drug Evaluation and Research Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated N/A *
April 27, 2006 Aquaharvest Seafood, LLC [ARCHIVED] Florida District Office Seafood HACCP/Adulterated N/A *
April 27, 2006 HemaCare Corporation [ARCHIVED] Los Angeles District Office Current Good Manufacturing Practices for Blood and Blood Components N/A *
April 26, 2006 Caribbean Cold Storage, Inc [ARCHIVED] Florida District Office Seafood HACCP/Adulterated N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-